BioMicro Systems Closes Series B Funding, Plans to Broaden Product Line | GenomeWeb
NEW YORK (GenomeWeb News) - BioMicro Systems said today it has closed a round of Series B financing with investors vSpring, Nanostart, and Staley Capital Advisors.
 
BioMicro, which markets the MAUI hybridization product line, did not disclose the amount of funding it received in this round, but said the new investments bring the total it has raised since inception to $10 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.